Showing results (1-10 of 274) with videos related to
Sort By:
Pageof 28
Frontiers in Oncology|May 21, 2016
Confronting the Care Delivery Challenges Arising from Precision MedicineElise C Kohn, S Percy IvyAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Whence High-Grade Serous Ovarian CancerElise C Kohn, S Percy IvyTrends in Cancer|July 26, 2017
The 'Pushmi-Pullyu' of DNA REPAIR: Clinical Synthetic LethalityS Percy Ivy, Johann de Bono, Elise C KohnClinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2017
The HRD Decision-Which PARP Inhibitor to Use for Whom and WhenElise C Kohn, Jung-Min Lee, S Percy IvyExpert Opinion on Investigational Drugs|August 27, 2019
Defining and targeting wild-type BRCA high-grade serous ovarian cancer: DNA repair and cell cycle checkpointsS Percy Ivy, Charles A Kunos, Fernanda I Arnaldez, et al.Expert Opinion on Investigational Drugs|February 23, 2016
Cediranib, a pan-VEGFR inhibitor, and olaparib, a PARP inhibitor, in combination therapy for high grade serous ovarian cancerS Percy Ivy, Joyce F Liu, Jung-Min Lee, et al.Cancer|February 26, 2020
Evaluation of toxicities related to novel therapy in clinical trials for women with gynecologic cancerYeh Chen Lee, Lisa Wang, Elise C Kohn, et al.JCO Clinical Cancer Informatics|January 18, 2019
Technology Applications: Use of Digital Health Technology to Enable Drug DevelopmentJoyce F Liu, Jung-Min Lee, Ellie Strock, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Molecular profiling and commercial predication assays in ovarian cancer: still not ready for prime time?Elise C KohnPageof 28